Results 221 to 230 of about 353,556 (317)
iPRISM: Intelligent Predicting Response to Cancer Immunotherapy through Systematic Modeling
The Intelligent Predicting Response to cancer Immunotherapy through Systematic Modeling (iPRISM) model uses data from genes and immune responses to predict how well cancer patients will respond to immunotherapy. Tested on multiple cancer types, iPRISM shows higher accuracy compared to existing methods.
Yinchun Su+7 more
wiley +1 more source
Periungual squamous cell carcinoma in childhood: a case report. [PDF]
Macedo-Pérez M+4 more
europepmc +1 more source
Myeloid immunosuppression and immune checkpoints in the tumor microenvironment
Kyohei Nakamura, M. Smyth
semanticscholar +1 more source
TP53‐Mutated Myeloid Neoplasms: 2024 Update on Diagnosis, Risk‐Stratification, and Management
ABSTRACT Alterations in the tumor suppressor gene TP53 are common in human cancers and are associated with an aggressive nature. Approximately 8%–12% of myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) harbor TP53 mutations (TP53mut) and present immense challenges due to inherent chemoresistance and poor outcomes.
Mithun Vinod Shah+2 more
wiley +1 more source
Native BK Viral Nephropathy After Pediatric Heart Transplantation Treated With Bilateral Native Nephrectomy and Living Donor Kidney Transplantation: A Case Report. [PDF]
Rachel K+5 more
europepmc +1 more source
ABSTRACT Allogeneic hematopoietic stem‐cell transplantation (HCT) remains the only potentially curative therapy for patients with myelodysplastic neoplasms (MDS) and myelofibrosis (MF) and is the standard care for eligible patients with higher‐risk disease. Despite significant advancements, both diseases pose unique challenges due to their clinical and
Nico Gagelmann, Nicolaus Kröger
wiley +1 more source
Checkpoint inhibitor therapy in immunosuppressed patients with Merkel cell carcinoma: not all immunosuppression is created equal. [PDF]
Brohl AS.
europepmc +1 more source